The U.S Food and Drug Administration notified four companies who have been illegally selling marijuana that the product does not prevent, diagnose, treat or cure cancer without evidence.
The statement which was released this week acknowledges an increase in the number of marijuana products that are falsely marketed. A compound found in the plant called tout cannabidiol (CBD) is specified.
Cannabidiol is currently tested by medical researchers for possible epilepsy treatments. However, it has not been approved by the FDA in any product, especially in marijuana.
“We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer” FDA Commissioner Scott Gottlieb emphasizes in the statement.
While the FDA is set on enforcing regulation for marijuana-containing products, CBD can be found on the market rather easily. The compound is sold in various products ranging from oil drop and capsules to syrups and creams.
The companies in question, Natural Alchemist, That’s Natural! Marketing and Consulting, Greenroads Health and Stanley Brothers Social Enteprises LLC claim that their products can treat Alzheimer’s and prevent tumor growths.
The FDA points out that false marketing can steer sick people from other reliable treatments capable of saving lives. As a result, the FDA has called for a response from the companies who are selling false treatment of how they will address these violations.So far three companies have corrected their approach while Greenroads Health was listed as “under maintenance” by the FDA. If other companies fail to follow FDA regulation, they will be met with legal action.
Breakthroughs in marijuana treatments are recognized by the FDA but they only acknowledge those that have a scientific basis. Only tried and tested treatments are allowed. Those that are supported by “unsubstantiated claims made on a website” will be weeded out.
Image Source: Wikimedia